Hostname: page-component-7dd5485656-7jgsp Total loading time: 0 Render date: 2025-10-31T10:07:39.136Z Has data issue: false hasContentIssue false
  • English
  • Français

NMS complicated by diazepam

Published online by Cambridge University Press:  02 January 2018

V. R. Velamoor
V. R. Velamoor*
Affiliation:
University of Western Ontario, 375 South Street, London, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Columns
Information
The British Journal of Psychiatry , Volume 160 , Issue 1 , January 1992 , pp. 135 - 136
Copyright
Copyright © The Royal College of Psychiatrists 

References

Finucane, P. & Murphy, S. F. (1984) Neuroleptic malignant syndrome – common or rare? (Abstract). Irish Journal of Medical Science, 153, 156.Google Scholar
Fricchione, G. L., Cassem, N. H., Hooberman, D. et al (1983) Intravenous lorazepam in neuroleptic-induced catatonia. Journal of Clinical Psychopharmacology, 3, 338–342.CrossRefGoogle ScholarPubMed
Lew, T. Y. & Tollefson, (1983) Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biological Psychiatry, 18, 1441–1446.Google Scholar
Serby, M. Neuroleptic malignant syndrome in Alzheimer's disease. Journal of the American Geriatric Society, 34, 895–896.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.